SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-161836
Filing Date
2015-04-30
Accepted
2015-04-30 16:10:18
Documents
16
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 6-K d916906d6k.htm 6-K 10592
2 EX-99.1 d916906dex991.htm EX-99.1 373142
3 EX-99.2 d916906dex992.htm EX-99.2 12628
4 EX-99.3 d916906dex993.htm EX-99.3 31330
5 EX-99.4 d916906dex994.htm EX-99.4 3701
6 GRAPHIC g916906page001.jpg GRAPHIC 21681
7 GRAPHIC g916906page002.jpg GRAPHIC 63960
8 GRAPHIC g916906page003.jpg GRAPHIC 12947
9 GRAPHIC g916906page004.jpg GRAPHIC 244164
10 GRAPHIC g916906page005.jpg GRAPHIC 182186
11 GRAPHIC g916906page006.jpg GRAPHIC 86333
12 GRAPHIC g916906page007.jpg GRAPHIC 25211
13 GRAPHIC g916906pc1a.jpg GRAPHIC 148142
14 GRAPHIC g916906pc2a.jpg GRAPHIC 273729
15 GRAPHIC g916906pc3a.jpg GRAPHIC 177517
16 GRAPHIC g916906pc4a.jpg GRAPHIC 325360
  Complete submission text file 0001193125-15-161836.txt   2585063
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 15818600
SIC: 2834 Pharmaceutical Preparations